APA (7th ed.) Citation

Köhler, B. C., Jassowicz, A., Scherr, A., Lorenz, S., Radhakrishnan, P., Kautz, N., . . . Schulze-Bergkamen, H. (2015). Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. BMC cancer, 15(1), . https://doi.org/10.1186/s12885-015-1929-y

Chicago Style (17th ed.) Citation

Köhler, Bruno Christian, et al. "Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling." BMC Cancer 15, no. 1 (2015). https://doi.org/10.1186/s12885-015-1929-y.

MLA (9th ed.) Citation

Köhler, Bruno Christian, et al. "Pan-Bcl-2 Inhibitor Obatoclax Is a Potent Late Stage Autophagy Inhibitor in Colorectal Cancer Cells Independent of Canonical Autophagy Signaling." BMC Cancer, vol. 15, no. 1, 2015, https://doi.org/10.1186/s12885-015-1929-y.